AZD-5672
Based on 1 publication(s) in Google Scholar
AZD-5672 is an orally active, potent, and selective CCR5 antagonist (IC50=0.32 nM). AZD-5672 shows moderate activity against the hERG ion channel (binding IC50=7.3 μM). AZD5672 is a substrate of human P-gp, and inhibits P-gp-mediated digoxin transport (IC50=32 μM). AZD-5672 can be used for the research of rheumatoid arthritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 95.74%
- No. CAS: 780750-65-4
- Fòrmula: C32H38F2N2O5S2
- Peso molecular:632.78
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-19974
TAK-220 -
HY-17377
Vicriviroc maleate -
HY-14882
Cenicriviroc -
HY-111069
Nifeviroc -
HY-14882A
Cenicriviroc Mesylate -
HY-N0797
(20S)-Protopanaxadiol -
HY-18611A
Abaucin -
HY-119293
K777 -
HY-12080A
BX471 hydrochloride -
HY-18611
Abaucin hydrochloride -
HY-17450A
Aplaviroc hydrochloride -
HY-133073
CCR7 Ligand 1
Publications Citing Use of MedChemExpress (MCE) AZD-5672
More
Actividad biológica
Descripciòn
|
CCR5 0.32 nM (IC50) |
hERG 7.3 μM (IC50) |
hP-gp 32 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
0.32 nM
Compound: 1
|
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
|
[PMID: 22266038] |
| CHO | IC50 |
0.32 nM
Compound: 9g
|
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
|
[PMID: 16631366] |
| HEK293 | IC50 |
7.3 μM
Compound: 1
|
Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs
Displacement of 3,7-Bis[2-(4-nitro[3,5-3H]phenyl)ethyl]-3,7-diazabicyclo[3.3.1]nonane from human ERG expressed in HEK cells after 3 hrs
|
[PMID: 22266038] |
| T-cell | IC50 |
0.12 nM
Compound: 9g
|
Inhibition of MIP-1-beta-stimulated calcium transient in human AlloT cells
Inhibition of MIP-1-beta-stimulated calcium transient in human AlloT cells
|
[PMID: 16631366] |
| T-cell | IC50 |
2.8 nM
Compound: 9g
|
Inhibition of MIP-1-beta-stimulated chemotaxis of human AlloT cells
Inhibition of MIP-1-beta-stimulated chemotaxis of human AlloT cells
|
[PMID: 16631366] |
In Vitro
AZD-5672 (0, 0.1, 0.3, 1, 3, 10, 30, and 100 μM) inhibits P-gp-mediated digoxin transport in a concentration-dependent manner (mean apparent IC50: 32 μM) in Caco-2 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
| Species | CIa (mL/min/kg) |
Vssa (L/kg) | t1/2a (h) | Fb (%) |
| Rat | 28 | 5.3 | 2.6 | 38 |
| Dog | 18 | 5.7 | 3.9 | 86 |
a AZD-5672 dosed 1-2 mg/kg i.v.
b AZD-5672 dosed 2-5 mg/kg p.o.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Ensayo clínico
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 780750-65-4
-
Appearance Solid
-
Peso molecular 632.78
-
Fòrmula C32H38F2N2O5S2
-
Color White to light brown
-
SMILES
O=C(N(C1CCN(CC[C@@H](C2=CC(F)=CC(F)=C2)C3=CC=C(S(=O)(C)=O)C=C3)CC1)CC)CC4=CC=C(S(=O)(C)=O)C=C4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvente y solubilidad
In Vitro:
DMSO : 33.33 mg/mL (52.67 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureza y Documentación
-
Ficha de datos (278 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Cumming JG, et al. Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1655-9. [Content Brief]
[2]. Elsby R, et al. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672. Drug Metab Dispos. 2011 Feb;39(2):275-82. [Content Brief]
[3]. Gerlag DM, et al. Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. Arthritis Rheum. 2010 Nov;62(11):3154-60. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.5803 mL | 7.9016 mL | 15.8033 mL | 39.5082 mL |
| 5 mM | 0.3161 mL | 1.5803 mL | 3.1607 mL | 7.9016 mL | |
| 10 mM | 0.1580 mL | 0.7902 mL | 1.5803 mL | 3.9508 mL | |
| 15 mM | 0.1054 mL | 0.5268 mL | 1.0536 mL | 2.6339 mL | |
| 20 mM | 0.0790 mL | 0.3951 mL | 0.7902 mL | 1.9754 mL | |
| 25 mM | 0.0632 mL | 0.3161 mL | 0.6321 mL | 1.5803 mL | |
| 30 mM | 0.0527 mL | 0.2634 mL | 0.5268 mL | 1.3169 mL | |
| 40 mM | 0.0395 mL | 0.1975 mL | 0.3951 mL | 0.9877 mL | |
| 50 mM | 0.0316 mL | 0.1580 mL | 0.3161 mL | 0.7902 mL |
AZD-5672 Related Classifications
HY-119101 Related Classifications
Powered by Bioz